Morgan Dempsey Capital Management LLC Sells 4,414 Shares of Electromed, Inc. (NYSE:ELMD)

Morgan Dempsey Capital Management LLC trimmed its holdings in Electromed, Inc. (NYSE:ELMD) by 63.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,498 shares of the company’s stock after selling 4,414 shares during the period. Morgan Dempsey Capital Management LLC’s holdings in Electromed were worth $74,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. IFP Advisors Inc bought a new position in shares of Electromed in the fourth quarter valued at $59,000. Barclays PLC purchased a new position in Electromed during the third quarter worth about $215,000. Wilmington Savings Fund Society FSB bought a new stake in Electromed in the 3rd quarter worth about $226,000. Legacy Wealth Asset Management LLC purchased a new stake in Electromed in the 4th quarter valued at about $253,000. Finally, Walleye Capital LLC bought a new position in shares of Electromed during the 3rd quarter worth approximately $274,000. 40.82% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Andrew Summers sold 12,731 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total value of $381,675.38. Following the transaction, the director now owns 165,755 shares in the company, valued at approximately $4,969,334.90. This represents a 7.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kathleen Skarvan sold 8,640 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $32.25, for a total value of $278,640.00. Following the completion of the transaction, the director now owns 71,576 shares in the company, valued at approximately $2,308,326. The trade was a 10.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 163,812 shares of company stock valued at $4,728,773 over the last three months. Corporate insiders own 14.00% of the company’s stock.

Electromed Stock Up 0.8 %

ELMD stock opened at $27.04 on Friday. The firm has a market cap of $231.38 million, a PE ratio of 36.05 and a beta of 0.33. The business has a 50 day moving average of $31.33 and a 200-day moving average of $25.69. Electromed, Inc. has a 12-month low of $13.74 and a 12-month high of $35.56.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ELMD shares. B. Riley started coverage on Electromed in a report on Thursday, February 20th. They issued a “buy” rating and a $38.00 target price for the company. StockNews.com lowered Electromed from a “strong-buy” rating to a “buy” rating in a report on Thursday.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.